Evaluation of protection against bovine viral diarrhea virus type 2 after vaccination of the calves with bovine viral diarrhea virus type 1 combo inactivated vaccine / Avaliação da proteção contra o vírus da diarreia viral bovina tipo 2 após vacinação de bezerros com vacina combinada inativada do vírus da diarreia viral bovina tipo 1

This study was designed to evaluate the extent of the protection for bovine viral diarrhea virus type 2 (BVDV-2) infection, afforded by vaccination with a combo inactivated vaccine, which contains bovine viral diarrhea virus type 1 (BVDV-1) and infectious bovine rhinotracheitis virus (IBRV). Five 3-4-month-old calves were intramuscularly vaccinated with a single dose of the combo vaccine and boosted with same dose three weeks after the first vaccination, with five mock immunized calves serving as a control group. Twenty-one days after the second vaccination, all calves were challenged with BVDV-2 SX08 strain by spray into nostril. The unvaccinated animals developed typical clinical signs of high rectal temperature, diarrhoea with erosions and a dramatic drop in leukocyte counts. These signs occured markedly less in all vaccinated animals, the rectal temperature, leukopenia and virarmia of which, were significantly less than the mock immunized calves. It can be concluded that vaccination with the combo inactivated vaccine affords cross-protection against clinical effects of a challenge-infection with BVDV-2 SX08 strain, although it was part protection.(AU)

Este estudo foi desenvolvido para avaliar a extensão da proteção contra a infecção pelo vírus da diarréia viral bovina tipo 2 (BVDV-2) através da vacinação com uma vacina combinada inativada contendo o vírus da diarréia viral bovina tipo 1 (BVDV-1) e vírus da rinotraqueíte de bovinos infecciosos (IBRV). Cinco bezerros com 3 a 4 meses de idade foram vacinados via intramuscular com uma dose única da vacina combinada e reforçados com a mesma dose três semanas após a primeira vacinação, com cinco bezerros imunizados em simulação servindo como grupo controle. Vinte e um dias após a segunda vacinação, todos os bezerros foram desafiados com a cepa BVDV-2 SX08 por spray na narina. Os animais não vacinados desenvolveram sinais clínicos típicos, como alta temperatura retal, diarréia com erosões e queda drástica na contagem de leucócitos. Estes sinais tiveram ocorrência significativamente menor em todos os animais vacinados, cuja temperatura retal, leucopenia e virarmia eram significativamente menores do que os bezerros simulados. É possível concluir que a vacinação com a vacina combinada inativada proporciona proteção cruzada contra os efeitos clínicos de uma infecção provocada pela cepa BVDV-2 SX08, embora tenha sido parcialmente protegida.(AU)

Evaluation of protection against bovine viral diarrhea virus type 2 after vaccination of the calves with bovine viral diarrhea virus type 1 combo inactivated vaccine / Avaliação da proteção contra o vírus da diarreia viral bovina tipo 2 após vacinação de bezerros com vacina combinada inativada do vírus da diarreia viral bovina tipo 1

This study was designed to evaluate the extent of the protection for bovine viral diarrhea virus type 2 (BVDV-2) infection, afforded by vaccination with a combo inactivated vaccine, which contains bovine viral diarrhea virus type 1 (BVDV-1) and infectious bovine rhinotracheitis virus (IBRV). Five 3-4-month-old calves were intramuscularly vaccinated with a single dose of the combo vaccine and boosted with same dose three weeks after the first vaccination, with five mock immunized calves serving as a control group. Twenty-one days after the second vaccination, all calves were challenged with BVDV-2 SX08 strain by spray into nostril. The unvaccinated animals developed typical clinical signs of high rectal temperature, diarrhoea with erosions and a dramatic drop in leukocyte counts. These signs occured markedly less in all vaccinated animals, the rectal temperature, leukopenia and virarmia of which, were significantly less than the mock immunized calves. It can be concluded that vaccination with the combo inactivated vaccine affords cross-protection against clinical effects of a challenge-infection with BVDV-2 SX08 strain, although it was part protection.(AU)

Este estudo foi desenvolvido para avaliar a extensão da proteção contra a infecção pelo vírus da diarréia viral bovina tipo 2 (BVDV-2) através da vacinação com uma vacina combinada inativada contendo o vírus da diarréia viral bovina tipo 1 (BVDV-1) e vírus da rinotraqueíte de bovinos infecciosos (IBRV). Cinco bezerros com 3 a 4 meses de idade foram vacinados via intramuscular com uma dose única da vacina combinada e reforçados com a mesma dose três semanas após a primeira vacinação, com cinco bezerros imunizados em simulação servindo como grupo controle. Vinte e um dias após a segunda vacinação, todos os bezerros foram desafiados com a cepa BVDV-2 SX08 por spray na narina. Os animais não vacinados desenvolveram sinais clínicos típicos, como alta temperatura retal, diarréia com erosões e queda drástica na contagem de leucócitos. Estes sinais tiveram ocorrência significativamente menor em todos os animais vacinados, cuja temperatura retal, leucopenia e virarmia eram significativamente menores do que os bezerros simulados. É possível concluir que a vacinação com a vacina combinada inativada proporciona proteção cruzada contra os efeitos clínicos de uma infecção provocada pela cepa BVDV-2 SX08, embora tenha sido parcialmente protegida.(AU)

Molecular characterization of the bovine IER3 gene: Down-regulation of IL-8 by blocking NF-κB activity mediated by IER3 overexpression in MDBK cells infected with bovine viral diarrhea virus-1.

The immediate early response 3 (IER3) is a key regulatory factor in the immune response, particularly as related to homeostasis immunomodulation via the nuclear factor kappa B (NF-κB) signaling pathway. The IER3 gene has been identified in mammals and, more recently, in other higher vertebrates. Nevertheless, relatively little is known about this regulator in bovines. Therefore, this study explored, characterized, and compared the genetic context of bovine IER3 to homologous genes in the human, mouse, and canine chromosomes. In silico analysis identified several regions of interest preserved in phylogenetically distant species. Similar analyses were also conducted for interleukin-8, a cytokine in which several putative cis elements were identified for the inducible transcription factor NF-κB. Subsequent challenge assays against the bovine viral diarrhea virus-1 revealed NF-κB signaling pathway activation just 15min post-infection, a process blocked by the BAY-117085 inhibitor. Similarly, infection strongly increased IER3 expression. Interestingly, IER3 down-regulated interleukin-8 expression, as confirmed by IER3 gene inhibition using small interfering RNA, RT-qPCR, and luciferase assays. In conclusion, this is the first report to present data indicating that bovine IER3 is a strong regulator of immune-marker expression, specifically modulating bovine interleukin-8 activation through the NF-κB/IER3 pathway in response to the bovine viral diarrhea virus.

Bovine A20 gene overexpression during bovine viral diarrhea virus-1 infection blocks NF-κB pathway in MDBK cells.

Viruses have developed cellular strategies to ensure progeny survival. One of the most interesting is immune camouflage, where the virus triggers a controlled-intensity immune response that prevents total destruction of the infected cell, thus "winning time" for the virus. This study explored the regulatory contexts of the bovine A20 gene during bovine viral diarrhea virus (BVDV)-1 infection, using IL-8 as an immune-response sentinel molecule. Assessments were conducted through RT-qPCR, Western blotting, gene silencing/overexpression, luciferase assays, and the use of pharmacological inhibitors, among other approaches. The results demonstrated that a) BVDV-1 increased A20 levels in Madin-Darby bovine kidney cells, b) increased A20 led to decreased IL-8 expression, and c) the virus affected the NF-κB signaling pathway. Collectively, these data identify bovine A20 as a strong regulator of immune marker expression. In conclusion, this is the first report on BVDV-1 modulating bovine IL-8 activation through the NF-κB/A20 pathway.

Transcriptomic analysis of responses to cytopathic bovine viral diarrhea virus-1 (BVDV-1) infection in MDBK cells.

The bovine viral diarrhea virus (BVDV) is responsible for significant economic losses in the dairy and cattle industry; however, little is known about the protective and pathological responses of hosts to infection. The present study determined the principal molecular markers implicated in viral infection through meta-transcriptomic analysis using MDBK cells infected for two hours with a field isolate of BVDV-1. While several immune regulator genes were induced, genes involved in cell signaling, metabolic processes, development, and integrity were down-regulated, suggesting an isolation of infected cells from cell-to-cell interactions and responses to external signals. Analysis through RT-qPCR confirmed the expression of more than one hundred markers. Interestingly, there was a significant up-regulation of two negative NF-κB regulators, IER3 and TNFAIP3, indicating a possible blocking of this signaling pathway mediated by BVDV-1 infection. Additionally, several genes involved in the metabolism of reactive oxygen species were down-regulated, suggesting increased oxidative stress. Notably, a number of genes involved in cellular growth and development were also regulated during infection, including MTHFD1L, TGIF1, and Brachyury. Moreover, there was an increased expression of the genes ß-catenin, caprin-2, GSK3ß, and MMP-7, all of which are crucial to the Wnt signaling pathway that is implicated in the embryonic development of a variety of organisms. This meta-transcriptomic analysis provides the first data towards understanding the infection mechanisms of cytopathic BVDV-1 and the putative molecular relationship between viral and host components.

Characterization of bovine A20 gene: Expression mediated by NF-κB pathway in MDBK cells infected with bovine viral diarrhea virus-1.

Cytokine production for immunological process is tightly regulated at the transcriptional and posttranscriptional levels. The NF-κB signaling pathway maintains immune homeostasis in the cell through the participation of molecules such as A20 (TNFAIP3), which is a key regulatory factor in the immune response, hematopoietic differentiation, and immunomodulation. Although A20 has been identified in mammals, and despite recent efforts to identify A20 members in other higher vertebrates, relatively little is known about the composition of this regulator in other classes of vertebrates, particularly for bovines. In this study, the genetic context of bovine A20 was explored and compared against homologous genes in the human, mouse, chicken, dog, and zebrafish chromosomes. Through in silico analysis, several regions of interest were found conserved between even phylogenetically distant species. Additionally, a protein-deduced sequence of bovine A20 evidenced many conserved domains in humans and mice. Furthermore, all potential amino acid residues implicated in the active site of A20 were conserved. Finally, bovine A20 mRNA expression as mediated by the bovine viral diarrhea virus and poly (I:C) was evaluated. These analyses evidenced a strong fold increase in A20 expression following virus exposure, a phenomenon blocked by a pharmacological NF-κB inhibitor (BAY 117085). Interestingly, A20 mRNA had a half-life of only 32min, likely due to adenylate- and uridylate-rich elements in the 3'-untranslated region. Collectively, these data identify bovine A20 as a regulator of immune marker expression. Finally, this is the first report to find the bovine viral diarrhea virus modulating bovine A20 activation through the NF-κB pathway.

Cytopathic BVDV-1 strain induces immune marker production in bovine cells through the NF-κB signaling pathway.

The bovine viral diarrhea virus (BVDV-1) is a pathogen responsible for high economic losses in the cattle industry worldwide. This virus has the capacity to modulate the immune system of several higher vertebrates, but there is little information available on the cell infection mechanism. To further investigate the effects of BVDV-1 on the activation of the immune response, the Madin-Darby bovine kidney cell line was infected with the cytopathic CH001 field isolate of BVDV-1, and the proinflammatory and antiviral cytokine expression profiles were analyzed. The results showed that BVDV-1 was able to induce the production of BCL3, IL-1ß, IL-8, IL-15, IL-18, Mx-1, IRF-1, and IRF-7 in a way similar to polyinosinic-polycytidylic acid. Interestingly, all BVDV-1 activities were blocked by pharmacological inhibitors of the NF-κB signaling pathway. These results, together with in silico analyses showing the presence of several regulatory consensus target motifs, suggest that BVDV-1 regulates gene expression in bovines through the activation of several key transcription factors. Collectively, these data identified BVDV-1 as a viral regulator of immune marker expression, even from early infection. Additionally, this is the first report to find BVDV-1 modulating the activation of cytokine production and transcriptions factors mainly through the NF-κB pathway in vertebrates.

The effects of reference genes in qRT-PCR assays for determining the immune response of bovine cells (MDBK) infected with the Bovine Viral Diarrhea Virus 1 (BVDV-1).

The bovine viral diarrhea virus (BVDV) causes significant economic losses to the dairy industry worldwide, and understanding its infection mechanisms would be extremely useful in designing new and efficient treatments. Due to the limited number of specific antibodies against bovine proteins, differential gene expression analyses are vital for researching host immune responses to viral infection. qRT-PCR provides a sensitive platform to conduct such gene expression analyses, but suitable housekeeping genes are needed for accurate transcript normalization. The present study assessed nine reference genes in bovine kidney cells under conditions of BVDV-1 infection, incubation with pathogen-associated molecular patterns, and co-incubation with BAY117085, a pharmacological inhibitor of the NF-κB signaling pathway. Analyses of Ct values using the BestKeeper and Normfinder programs ranked CD81, RPL4, and GAPDH as the most reliable reference genes. This determination of a stable set of reference genes in this culture system will facilitate analyses of expression levels for genes of interest.

Occurrence of neutralizing antibodies against BVDV-1 and BVDV-2 in cattle herds from Minas Gerais and São Paulo States, Brazil / Ocorrência de anticorpos neutralizantes contra o BVDV-1 e o BVDV-2 em rebanhos bovinos de Minas Gerais e São Paulo, Brasil

The occurrence of neutralizing antibodies against bovine viral diarrhea virus genotypes (BVDV-1 and BVDV-2) has been confirmed by virus neutralization test (VN) in samples of blood serum from 26 cattle herds which were not BVDV vaccinated, located in the states of Minas Gerais and São Paulo, Brazil. Ten blood samples were collected from each herd, five samples from 6 to 12-month-old calves and five samples from adult bovines. Of the total samples analyzed, 102 (39.2%) were reactive to BVDV, more specifically, 81 (31.1%) were reactive to BVDV-1 and BVDV-2, seven (2.7%) were reactive to BVDV-1 only and 14 (5.4%) were reactive to BVDV-2 only. Except for two herds, in all others at least one animal was detected reactive to BVDV, however, one of them was reactive to BVDV-2 only. In six herds, neutralizing antibodies were detected in blood serum from 6 to 12-month-old calves. Therefore, were indicative of recent BVDV infection and also suggested the likely presence of an infection source in the herd. The results showed the occurrence of neutralizing antibodies against BVDV genotypes in cattle herds located in the states analyzed, but these same results demonstrated the differences in the number of bovines reactive for BVDV-1 and BVDV-2, thus demonstrating the need to use strains from each genotype in VN tests for serological diagnosis of BVDV.

A ocorrência de anticorpos neutralizantes contra os genótipos do vírus da diarréia viral bovina (BVDV-1 e BVDV-2) foi determinada pelo teste de virusneutralização (VN) em amostras de soro sangüíneo provenientes de 26 rebanhos bovinos não vacinados contra o BVDV, localizados nos Estados de Minas Gerais e São Paulo, Brasil. Foram analisadas 10 amostras por rebanho, sendo cinco de bovinos adultos e cinco de bovinos com idade entre 6 e 12 meses. Do total de 260 amostras analisadas, 102 (39,2%) reagiram ao BVDV, das quais 81 (31,1%) foram reagentes tanto ao BVDV-1 quanto ao BVDV-2, sete (2,7%) reagiram apenas ao BVDV-1 e 14 (5,4%) reagiram apenas ao BVDV-2. Com exceção de dois rebanhos, nos demais foram detectados pelo menos um animal reagente ao BVDV, entretanto, foram detectados animais reagentes apenas ao BVDV-2 em um deles. Em seis rebanhos foram detectados anticorpos neutralizantes nos bovinos da faixa etária de 6 a 12 meses, sendo, portanto, indicativos da infecção recente pelo vírus e também sugestivos da provável presença da fonte de infecção no rebanho. Os dados obtidos mostraram a ocorrência de anticorpos neutralizantes contra os genótipos do BVDV em rebanhos bovinos localizados nos Estados analisados, mas os resultados apresentaram diferenças no número de bovinos reagentes ao BVDV-1 e ao BVDV-2, ressaltando assim a necessidade da utilização de estirpes de cada genótipo nos testes de VN para o diagnóstico sorológico do BVDV.

Ocorrência de animais persistentemente infectados pelo vírus da diarréia viral bovina em rebanhos bovinos nos Estados de Minas Gerais e São Paulo / Occurrence of persistently infected animals with bovine viral diarrhoea virus in cattle herds from the States of Minas Gerais and São Paulo, Brazil

A pesquisa de animais persistentemente infectados (PI) pelo vírus da diarréia viral bovina (BVDV) foi realizada em 26 rebanhos bovinos, não vacinados contra o BVDV, localizados nos Estados de Minas Gerais e São Paulo, Brasil. Utilizando uma estratégia de amostragem, de cada rebanho foram obtidas cinco amostras de sangue de bezerros, entre 6 e 12 meses de idade, e os soros sanguíneos foram submetidos ao teste de virusneutralização (VN) para o BVDV-1 e o BVDV-2. Os rebanhos que apresentaram pelo menos três das cinco amostras reagentes a um dos genótipos do BVDV, e com títulos de anticorpos superiores a 128, foram selecionados para a pesquisa de animais PI. Em três rebanhos que apresentaram tal condição, foram colhidas amostras pareadas de sangue de todos os bovinos do rebanho, com intervalo de 30 dias entre as colheitas, e o soro sanguíneo foi submetido ao teste de VN para o BVDV-1 e o BVDV-2. Nas amostras não reagentes a pelo menos um dos genótipos do BVDV e naquelas provenientes de bovinos com menos de seis meses de idade, realizou-se a pesquisa do BVDV pela reação em cadeia da polimerase precedida pela transcrição reversa (RT-PCR). Dos rebanhos analisados, foram detectados dois animais PI a partir de amostras obtidas nas colheitas pareadas provenientes de um rebanho localizado no Estado de Minas Gerais.

The research on persistently infected (PI) animals with bovine viral diarrhoea virus (BVDV) was conducted in 26 cattle herds, which were not BVDV vaccinated, located in the states of Minas Gerais and São Paulo, Brazil. Using a sampling strategy, five samples of blood were collected from 6 to 12-month-old calves of each herd, and the blood sera were tested by virusneutralization test (VN) to BVDV-1 and BVDV-2. The herds that had at least three out of five samples reacting to one of the genotypes of BVDV and antibody titers greater than 128 were selected to PI animals research. In three of the herds that matched the before-mentioned criteria, paired blood samples were collected from all its individuals considering a collection interval of 30 days. The blood sera of these samples were VN tested against BVDV-1 and BVDV-2. In samples not reacting to at least one of the BVDV genotypes and also in those collected from calves of less than six months of age, virus research was undertaken by reverse transcription polymerase chain reaction (RT-PCR). From the examined herds, two PI animals were detected in paired samples obtained from a herd located in the state of Minas Gerais.

Ocorrência de animais persistentemente infectados pelo vírus da diarréia viral bovina em rebanhos bovinos nos Estados de Minas Gerais e São Paulo / Occurrence of persistently infected animals with bovine viral diarrhoea virus in cattle herds from the States of Minas Gerais and São Paulo, Brazil

A pesquisa de animais persistentemente infectados (PI) pelo vírus da diarréia viral bovina (BVDV) foi realizada em 26 rebanhos bovinos, não vacinados contra o BVDV, localizados nos Estados de Minas Gerais e São Paulo, Brasil. Utilizando uma estratégia de amostragem, de cada rebanho foram obtidas cinco amostras de sangue de bezerros, entre 6 e 12 meses de idade, e os soros sanguíneos foram submetidos ao teste de virusneutralização (VN) para o BVDV-1 e o BVDV-2. Os rebanhos que apresentaram pelo menos três das cinco amostras reagentes a um dos genótipos do BVDV, e com títulos de anticorpos superiores a 128, foram selecionados para a pesquisa de animais PI. Em três rebanhos que apresentaram tal condição, foram colhidas amostras pareadas de sangue de todos os bovinos do rebanho, com intervalo de 30 dias entre as colheitas, e o soro sanguíneo foi submetido ao teste de VN para o BVDV-1 e o BVDV-2. Nas amostras não reagentes a pelo menos um dos genótipos do BVDV e naquelas provenientes de bovinos com menos de seis meses de idade, realizou-se a pesquisa do BVDV pela reação em cadeia da polimerase precedida pela transcrição reversa (RT-PCR). Dos rebanhos analisados, foram detectados dois animais PI a partir de amostras obtidas nas colheitas pareadas provenientes de um rebanho localizado no Estado de Minas Gerais.(AU)

The research on persistently infected (PI) animals with bovine viral diarrhoea virus (BVDV) was conducted in 26 cattle herds, which were not BVDV vaccinated, located in the states of Minas Gerais and São Paulo, Brazil. Using a sampling strategy, five samples of blood were collected from 6 to 12-month-old calves of each herd, and the blood sera were tested by virusneutralization test (VN) to BVDV-1 and BVDV-2. The herds that had at least three out of five samples reacting to one of the genotypes of BVDV and antibody titers greater than 128 were selected to PI animals research. In three of the herds that matched the before-mentioned criteria, paired blood samples were collected from all its individuals considering a collection interval of 30 days. The blood sera of these samples were VN tested against BVDV-1 and BVDV-2. In samples not reacting to at least one of the BVDV genotypes and also in those collected from calves of less than six months of age, virus research was undertaken by reverse transcription polymerase chain reaction (RT-PCR). From the examined herds, two PI animals were detected in paired samples obtained from a herd located in the state of Minas Gerais.(AU)

Comparação dos testes de virusneutralização contra os genótipos 1 e 2 do vírus da diarreia viral bovina (BVDV-1 e BVDV-2) em bovinos de rebanhos naturalmente infectados / Comparison of virusneutralization tests against genotypes 1 and 2 of the bovine viral diarrhoea virus (BVDV-1 and BVDV-2) in cattle of naturally infected herds

Os resultados dos testes de virusneutralização (VN) contra os genótipos do vírus da diarreia viral bovina (BVDV-1 e BVDV-2), bem como os respectivos títulos de anticorpos, foram comparados em 1.925 amostras de soro sanguíneo obtidas de rebanhos bovinos naturalmente infectados e não vacinados contra o BVDV, provenientes dos Estados de São Paulo e Minas Gerais. A proporção de amostras reagentes entre os genótipos foi analisada pelo Teste de McNemar, e os títulos de anticorpos das amostras reagentes ao BVDV-1 e ao BVDV-2 foram comparados pelo Teste de Wilcoxon. Não foi verificada discordância na proporção de bovinos reagentes ao BVDV-1 e ao BVDV-2 (P>0,05). No entanto, houve discordância entre os títulos de anticorpos detectados nos testes de VN contra os genótipos 1 e 2 do BVDV (P<0,0001). Embora a proporção de animais reagentes contra ambos os genótipos do BVDV tenha sido semelhante, resultados falso-negativos seriam obtidos se 67 amostras (3,5 por cento) tivessem sido submetidas apenas ao teste de VN, para o BVDV-1, e em 51 amostras (2,65 por cento), apenas para o BVDV-2. Alguns rebanhos apresentaram títulos de anticorpos superiores para o BVDV-1, enquanto outros para BVDV-2, demonstrando assim a ocorrência da infecção pelos diferentes genótipos do vírus entre os rebanhos analisados. Portanto, tais resultados demonstraram a necessidade da inclusão de ambos os genótipos do BVDV nos testes de VN.

The virusneutralization test (VN) results against bovine viral diarrhoea virus genotypes (BVDV-1 and BVDV-2), and the respective titers of antibodies, were compared in 1,925 serum samples collected from unvaccinated and naturally infected cattle herds, located in the states of São Paulo and Minas Gerais, Brazil. The proportion of reagent samples among the genotypes was evaluated by McNemar test and the antibody titers against BVDV-1 and BVDV-2 were compared by Wilcoxon test. There were no disagreement in the proportion of BVDV-1 and BVDV-2 reagent samples (P>0.05). However, there was a disagreement among titers of antibodies detected in the VN tests against BVDV genotypes (P<0.0001). Although the proportion of reagent animals to BVDV genotypes was similar, false negative results would be obtained if 67 samples (3.5 percent) had been submitted only to VN test against BVDV-1, and 51 samples (2.65 percent) only against BVDV-2. Some herds had higher titers of antibodies for BVDV-1, while others for BVDV-2, thus demonstrating the occurrence of infection by different virus genotypes among the analyzed herds. Therefore, these results demonstrated the need for inclusion of both BVDV genotypes in VN tests.

Comparação dos testes de virusneutralização contra os genótipos 1 e 2 do vírus da diarreia viral bovina (BVDV-1 e BVDV-2) em bovinos de rebanhos naturalmente infectados

The virusneutralization test (VN) results against bovine viral diarrhoea virus genotypes (BVDV-1 and BVDV-2), and the respective titers of antibodies, were compared in 1,925 serum samples collected from unvaccinated and naturally infected cattle herds, located in the states of São Paulo and Minas Gerais, Brazil. The proportion of reagent samples among the genotypes was evaluated by McNemar test and the antibody titers against BVDV-1 and BVDV-2 were compared by Wilcoxon test. There were no disagreement in the proportion of BVDV-1 and BVDV-2 reagent samples (P>0.05). However, there was a disagreement among titers of antibodies detected in the VN tests against BVDV genotypes (P 0.0001). Although the proportion of reagent animals to BVDV genotypes was similar, false negative results would be obtained if 67 samples (3.5%) had been submitted only to VN test against BVDV-1, and 51 samples (2.65%) only against BVDV-2. Some herds had higher titers of antibodies for BVDV-1, while others for BVDV-2, thus demonstrating the occurrence of infection by different virus genotypes among the analyzed herds. Therefore, these results demonstrated the need for inclusion of both BVDV genotypes in VN tests.

Os resultados dos testes de virusneutralização (VN) contra os genótipos do vírus da diarreia viral bovina (BVDV-1 e BVDV-2), bem como os respectivos títulos de anticorpos, foram comparados em 1.925 amostras de soro sanguíneo obtidas de rebanhos bovinos naturalmente infectados e não vacinados contra o BVDV, provenientes dos Estados de São Paulo e Minas Gerais. A proporção de amostras reagentes entre os genótipos foi analisada pelo Teste de McNemar, e os títulos de anticorpos das amostras reagentes ao BVDV-1 e ao BVDV-2 foram comparados pelo Teste de Wilcoxon. Não foi verificada discordância na proporção de bovinos reagentes ao BVDV-1 e ao BVDV-2 (P>0,05). No entanto, houve discordância entre os títulos de anticorpos detectados nos testes de VN contra os genótipos 1 e 2 do BVDV (P 0,0001). Embora a proporção de animais reagentes contra ambos os genótipos do BVDV tenha sido semelhante, resultados falso-negativos seriam obtidos se 67 amostras (3,5%) tivessem sido submetidas apenas ao teste de VN, para o BVDV-1, e em 51 amostras (2,65%), apenas para o BVDV-2. Alguns rebanhos apresentaram títulos de anticorpos superiores para o BVDV-1, enquanto outros para BVDV-2, demonstrando assim a ocorrência da infecção pelos diferentes genótipos do vírus entre os rebanhos analisados. Portanto, tais resultados demonstraram a necessidade da inclusão de ambos os genótipos do BVDV nos testes de VN.

Comparação dos testes de virusneutralização contra os genótipos 1 e 2 do vírus da diarreia viral bovina (BVDV-1 e BVDV-2) em bovinos de rebanhos naturalmente infectados

The virusneutralization test (VN) results against bovine viral diarrhoea virus genotypes (BVDV-1 and BVDV-2), and the respective titers of antibodies, were compared in 1,925 serum samples collected from unvaccinated and naturally infected cattle herds, located in the states of São Paulo and Minas Gerais, Brazil. The proportion of reagent samples among the genotypes was evaluated by McNemar test and the antibody titers against BVDV-1 and BVDV-2 were compared by Wilcoxon test. There were no disagreement in the proportion of BVDV-1 and BVDV-2 reagent samples (P>0.05). However, there was a disagreement among titers of antibodies detected in the VN tests against BVDV genotypes (P 0.0001). Although the proportion of reagent animals to BVDV genotypes was similar, false negative results would be obtained if 67 samples (3.5%) had been submitted only to VN test against BVDV-1, and 51 samples (2.65%) only against BVDV-2. Some herds had higher titers of antibodies for BVDV-1, while others for BVDV-2, thus demonstrating the occurrence of infection by different virus genotypes among the analyzed herds. Therefore, these results demonstrated the need for inclusion of both BVDV genotypes in VN tests.

Os resultados dos testes de virusneutralização (VN) contra os genótipos do vírus da diarreia viral bovina (BVDV-1 e BVDV-2), bem como os respectivos títulos de anticorpos, foram comparados em 1.925 amostras de soro sanguíneo obtidas de rebanhos bovinos naturalmente infectados e não vacinados contra o BVDV, provenientes dos Estados de São Paulo e Minas Gerais. A proporção de amostras reagentes entre os genótipos foi analisada pelo Teste de McNemar, e os títulos de anticorpos das amostras reagentes ao BVDV-1 e ao BVDV-2 foram comparados pelo Teste de Wilcoxon. Não foi verificada discordância na proporção de bovinos reagentes ao BVDV-1 e ao BVDV-2 (P>0,05). No entanto, houve discordância entre os títulos de anticorpos detectados nos testes de VN contra os genótipos 1 e 2 do BVDV (P 0,0001). Embora a proporção de animais reagentes contra ambos os genótipos do BVDV tenha sido semelhante, resultados falso-negativos seriam obtidos se 67 amostras (3,5%) tivessem sido submetidas apenas ao teste de VN, para o BVDV-1, e em 51 amostras (2,65%), apenas para o BVDV-2. Alguns rebanhos apresentaram títulos de anticorpos superiores para o BVDV-1, enquanto outros para BVDV-2, demonstrando assim a ocorrência da infecção pelos diferentes genótipos do vírus entre os rebanhos analisados. Portanto, tais resultados demonstraram a necessidade da inclusão de ambos os genótipos do BVDV nos testes de VN.

Comparação dos testes de virusneutralização contra os genótipos 1 e 2 do vírus da diarreia viral bovina (BVDV-1 e BVDV-2) em bovinos de rebanhos naturalmente infectados

The virusneutralization test (VN) results against bovine viral diarrhoea virus genotypes (BVDV-1 and BVDV-2), and the respective titers of antibodies, were compared in 1,925 serum samples collected from unvaccinated and naturally infected cattle herds, located in the states of São Paulo and Minas Gerais, Brazil. The proportion of reagent samples among the genotypes was evaluated by McNemar test and the antibody titers against BVDV-1 and BVDV-2 were compared by Wilcoxon test. There were no disagreement in the proportion of BVDV-1 and BVDV-2 reagent samples (P>0.05). However, there was a disagreement among titers of antibodies detected in the VN tests against BVDV genotypes (P 0.0001). Although the proportion of reagent animals to BVDV genotypes was similar, false negative results would be obtained if 67 samples (3.5%) had been submitted only to VN test against BVDV-1, and 51 samples (2.65%) only against BVDV-2. Some herds had higher titers of antibodies for BVDV-1, while others for BVDV-2, thus demonstrating the occurrence of infection by different virus genotypes among the analyzed herds. Therefore, these results demonstrated the need for inclusion of both BVDV genotypes in VN tests.

Os resultados dos testes de virusneutralização (VN) contra os genótipos do vírus da diarreia viral bovina (BVDV-1 e BVDV-2), bem como os respectivos títulos de anticorpos, foram comparados em 1.925 amostras de soro sanguíneo obtidas de rebanhos bovinos naturalmente infectados e não vacinados contra o BVDV, provenientes dos Estados de São Paulo e Minas Gerais. A proporção de amostras reagentes entre os genótipos foi analisada pelo Teste de McNemar, e os títulos de anticorpos das amostras reagentes ao BVDV-1 e ao BVDV-2 foram comparados pelo Teste de Wilcoxon. Não foi verificada discordância na proporção de bovinos reagentes ao BVDV-1 e ao BVDV-2 (P>0,05). No entanto, houve discordância entre os títulos de anticorpos detectados nos testes de VN contra os genótipos 1 e 2 do BVDV (P 0,0001). Embora a proporção de animais reagentes contra ambos os genótipos do BVDV tenha sido semelhante, resultados falso-negativos seriam obtidos se 67 amostras (3,5%) tivessem sido submetidas apenas ao teste de VN, para o BVDV-1, e em 51 amostras (2,65%), apenas para o BVDV-2. Alguns rebanhos apresentaram títulos de anticorpos superiores para o BVDV-1, enquanto outros para BVDV-2, demonstrando assim a ocorrência da infecção pelos diferentes genótipos do vírus entre os rebanhos analisados. Portanto, tais resultados demonstraram a necessidade da inclusão de ambos os genótipos do BVDV nos testes de VN.